Our findings emphasize the implication of epithelial Notch-1 in i) controlling intestinal tumorigenesis, and, ii) highlighting a molecular signature in a subset of patients with colorectal mucinous adenocarcinoma that may benefit from targeted screening and subsequent therapeutics. This evidence concerns the gene NOTCH1 and colorectal mucinous adenocarcinoma.